Curiosis Inc
494120
Company Profile
Business description
Curiosis Inc develops, manufactures, and supplies bioresearch equipment, laboratory automation products, and medical devices designed to support laboratory automation and life science research. The company’s product portfolio encompasses high performance cell imaging instrumentation, cell counting and isolation systems, digital pathology platforms, colony picking robots, and related lab automation infrastructure.
Contact
10 Teheran-ro 38-gil
4th floor, Gangnam-gu
Seoul
KORT: +82 25085236
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
79
Stocks News & Analysis
stocks
Hostile takeover on the cards for this ASX income opportunity
IFM lobs reasonable takeover offer.
stocks
Get ready for major US tech earnings starting tomorrow morning
Microsoft, Amazon, Alphabet, and Meta will all release quarterly earnings. Here’s what analysts are looking for.
stocks
Corning’s AI fiber boom is real, but its stock price may be getting out of hand
Corning’s optical fiber business is thriving, and the Meta deal derisks its supply buildout, but success isn’t guaranteed.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,915.70 | 16.00 | 0.18% |
| CAC 40 | 8,049.67 | 54.42 | -0.67% |
| DAX 40 | 23,897.61 | 120.65 | -0.50% |
| Dow JONES (US) | 48,872.76 | 269.17 | -0.55% |
| FTSE 100 | 10,203.29 | 129.50 | -1.25% |
| HKSE | 26,111.84 | 432.06 | 1.68% |
| NASDAQ | 24,606.89 | 56.91 | -0.23% |
| Nikkei 225 | 59,917.46 | 619.90 | -1.02% |
| NZX 50 Index | 12,770.30 | 5.90 | 0.05% |
| S&P 500 | 7,123.81 | 14.99 | -0.21% |
| S&P/ASX 200 | 8,687.00 | 9.40 | 0.11% |
| SSE Composite Index | 4,107.51 | 28.88 | 0.71% |